Chemoinformaics analysis of HydroxySitosterol
| Molecular Weight | 430.717 | nRot | 6 |
| Heavy Atom Molecular Weight | 380.317 | nRig | 20 |
| Exact Molecular Weight | 430.381 | nRing | 4 |
| Solubility: LogS | -5.489 | nHRing | 0 |
| Solubility: LogP | 6.225 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 83.3736 |
| nHD | 2 | BPOL | 50.1604 |
| QED | 0.446 |
| Synth | 4.618 |
| Natural Product Likeliness | 2.854 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.475 |
| Pgp-sub | 0.009 |
| HIA | 0.007 |
| CACO-2 | -4.773 |
| MDCK | 0.0000169 |
| BBB | 0.761 |
| PPB | 0.98616 |
| VDSS | 1.287 |
| FU | 0.0188082 |
| CYP1A2-inh | 0.033 |
| CYP1A2-sub | 0.61 |
| CYP2c19-inh | 0.055 |
| CYP2c19-sub | 0.957 |
| CYP2c9-inh | 0.101 |
| CYP2c9-sub | 0.504 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.554 |
| CYP3a4-inh | 0.172 |
| CYP3a4-sub | 0.777 |
| CL | 13.518 |
| T12 | 0.018 |
| hERG | 0.03 |
| Ames | 0.029 |
| ROA | 0.505 |
| SkinSen | 0.026 |
| Carcinogencity | 0.029 |
| EI | 0.007 |
| Respiratory | 0.808 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.686287 |